Tenderwize
Back to tender search

Open House Drug Discount Agreements Brinzolamid and Brimonidin, ATC S01EC24

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Feb 05, 2027 · 173 days left·Open·Supplies·Framework
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Brinzolamid und Brimonidin, ATC S01EC24

40/100

Opportunity Score

Needs reviewLow complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

40 / 100

Complexity

20 / 100

Risk factors

No guaranteed minimum volume or sales; agreements are non-exclusive and can be overridden by other discount contracts.

Strict submission rules: paper documents require two original copies, and electronic submissions require qualified elec...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Mar 2027
  • Non-exclusive pharmaceutical rebate agreements for Brinzolamid and Brimonidin (ATC S01EC24)
  • Agreements are identical and non-negotiable
Show full summary

This is an open-house model for non-exclusive rebate agreements for the active substances Brinzolamid and Brimonidin (ATC S01EC24) with AOK Bayern. It is not a standard procurement procedure; any qualified pharmaceutical company can enter into identical, non-negotiable agreements. The contract runs from April 1, 2025 to March 31, 2027, with possible entry anytime until February 5, 2027.

Risks

No guaranteed minimum volume or sales; agreements are non-exclusive and can be overridden by other discount contracts.

Strict submission rules: paper documents require two original copies, and electronic submissions require qualified elec...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Only pharmaceutical companies may participate

Administrative

  • Submit signed self-declaration of reliability
  • Submit signed contract and annex listing the specific drugs

Requirements may be incomplete.

Award Criteria

Lot 1

Eligibility based on self-declaration of reliability; no competitive award criteria.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open House Drug Discount Agreements Brinzolamid and Brimonidin, ATC S01EC24

Non-exclusive rebate agreements for the specified active substances, open to all qualified pharmaceutical companies.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Mar 2025 - Mar 2027

Category

Pharmaceutical products

Award Criteria

Eligibility based on self-declaration of reliability; no competitive award criteria.

Deadline

Deadline Feb 05, 2027

Procurement Details

Publication date
17 Feb 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
106957-2025

Documents (2)

Similar tenders